These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
538 related articles for article (PubMed ID: 31330079)
1. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition. Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors. Wang G; Peng Z; Wang J; Li X; Li J Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725 [TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study. Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors. Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors. Saeedi M; Mohammadi-Khanaposhtani M; Asgari MS; Eghbalnejad N; Imanparast S; Faramarzi MA; Larijani B; Mahdavi M; Akbarzadeh T Bioorg Med Chem; 2019 Dec; 27(23):115148. PubMed ID: 31679980 [TBL] [Abstract][Full Text] [Related]
6. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies. Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors. Wang G; Peng Z; Wang J; Li J; Li X Bioorg Med Chem Lett; 2016 Dec; 26(23):5719-5723. PubMed ID: 27810241 [TBL] [Abstract][Full Text] [Related]
8. Isatin based Schiff bases as inhibitors of α-glucosidase: Synthesis, characterization, in vitro evaluation and molecular docking studies. Rahim F; Malik F; Ullah H; Wadood A; Khan F; Javid MT; Taha M; Rehman W; Ur Rehman A; Khan KM Bioorg Chem; 2015 Jun; 60():42-8. PubMed ID: 25955493 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, α-glucosidase inhibitory activity, and molecular dynamic simulation of 6-chloro-2-methoxyacridine linked to triazole derivatives. Asadi M; Ahangari MM; Iraji A; Azizian H; Nokhbehzaim A; Bahadorikhalili S; Mojtabavi S; Faramarzi MA; Nasli-Esfahani E; Larijani B; Mahdavi M; Amanlou M Sci Rep; 2024 Jul; 14(1):17338. PubMed ID: 39069559 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro evaluation, and molecular docking studies of novel hydrazineylideneindolinone linked to phenoxymethyl-1,2,3-triazole derivatives as potential α-glucosidase inhibitors. Shareghi-Boroujeni D; Iraji A; Mojtabavi S; Faramarzi MA; Akbarzadeh T; Saeedi M Bioorg Chem; 2021 Jun; 111():104869. PubMed ID: 33839583 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, in vitro alpha-glucosidase inhibitory potential of benzimidazole bearing bis-Schiff bases and their molecular docking study. Rahim F; Zaman K; Taha M; Ullah H; Ghufran M; Wadood A; Rehman W; Uddin N; Shah SAA; Sajid M; Nawaz F; Khan KM Bioorg Chem; 2020 Jan; 94():103394. PubMed ID: 31699396 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, in vitro, and in silico anti-α-glucosidase assays of N-phenylacetamide-1,2,3-triazole-indole-2-carboxamide derivatives as new anti-diabetic agents. Sayahi MH; Zareei S; Halimi M; Alikhani M; Moazzam A; Mohammadi-Khanaposhtani M; Mojtabavi S; Faramarzi MA; Rastegar H; Taslimi P; Ibrahim EH; Ghramh HA; Larijani B; Mahdavi M Sci Rep; 2024 Jul; 14(1):15791. PubMed ID: 38982268 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors. Wang G; Wang J; He D; Li X; Li J; Peng Z Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion. Ye GJ; Lan T; Huang ZX; Cheng XN; Cai CY; Ding SM; Xie ML; Wang B Eur J Med Chem; 2019 Sep; 177():362-373. PubMed ID: 31158750 [TBL] [Abstract][Full Text] [Related]
15. Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies. Yeye EO; Kanwal ; Mohammed Khan K; Chigurupati S; Wadood A; Ur Rehman A; Perveen S; Kannan Maharajan M; Shamim S; Hameed S; Aboaba SA; Taha M Bioorg Med Chem; 2020 Jun; 28(11):115467. PubMed ID: 32327353 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, molecular docking study, and α-glucosidase inhibitory evaluation of novel hydrazide-hydrazone derivatives of 3,4-dihydroxyphenylacetic acid. Khan H; Jan F; Shakoor A; Khan A; AlAsmari AF; Alasmari F; Ullah S; Al-Harrasi A; Khan M; Ali S Sci Rep; 2024 May; 14(1):11410. PubMed ID: 38762658 [TBL] [Abstract][Full Text] [Related]
17. New phenylthiosemicarbazide-phenoxy-1,2,3-triazole-N-phenylacetamides as dual inhibitors against α-glucosidase and PTP-1B for the treatment of type 2 diabetes. Ansariashlaghi S; Fakhrioliaei A; Mohammadi-Khanaposhtani M; Noori M; Asadi M; Mojtabavi S; Faramarzi MA; Esfahani EN; Rastegar H; Larijani B; Azizian H; Mahdavi M Arch Pharm (Weinheim); 2024 Jul; 357(7):e2300517. PubMed ID: 38593290 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of α-glucosidase enzyme by 'click'-inspired pharmacophore framework 1,3,4-thiadiazole-1,2,3-triazole hybrids. Dhameja M; Kumar H; Kurella S; Singh R; Uma A; Gupta P Future Med Chem; 2023 Feb; 15(4):345-363. PubMed ID: 36942781 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of 1H-1,2,3-triazole derivatives as new α-glucosidase inhibitors and their molecular docking studies. Avula SK; Khan A; Rehman NU; Anwar MU; Al-Abri Z; Wadood A; Riaz M; Csuk R; Al-Harrasi A Bioorg Chem; 2018 Dec; 81():98-106. PubMed ID: 30118991 [TBL] [Abstract][Full Text] [Related]
20. Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors. Chaudhry F; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Munir R; Sohail R; Jahan B; Munawar MA; Khan MA Bioorg Chem; 2017 Aug; 73():1-9. PubMed ID: 28521172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]